EMA Issues Q&A on Health-Based Exposure Limits

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency released Q&A guidance on prevention of cross-contamination and setting health-based exposure limits (HBELs) for risk identification during drug manufacturing in shared facilities.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor